title: Phospholipids and a phospholipid-rich diet alter the in vitro amyloid-beta peptide levels and amyloid-beta 42/40 ratios.
abstract: Amyloid-beta peptides (Abeta) generated by proteolysis of the beta-amyloid precursor protein (APP) by beta- and gamma-secretases play an important role in the pathogenesis of Alzheimer's disease (AD). There is mounting evidence that the lipid matrix of neuronal cell membranes plays an important role in the accumulation of Abeta peptides into senile plaques, one of the hallmarks of AD. With the aim to clarify the molecular basis of the interaction between Abeta and cellular membranes, we investigated the effects of various phospholipids (PLs) and a PL-rich diet on Abeta production. Here we show that modulation of Abeta production and Abeta42:40 ratio is not limited to individual fatty acids, rather it is the composition of the PLs of the membrane bilayer, that influences the specificity and level of the regulated intramembranous proteolysis of APP by the gamma-secretase complex. We show that Abeta levels in the conditioned media, in response to some of the PL supplements, is increased in the center and decreased on either side of a graph that resembles bell-shaped distribution. This means that the PLs have less of a tendency to produce unusually extreme effects on Abeta production in SP-C99 transfected Cos-7 cultured cells. We proposed a mechanism-based hypothesis to rationalize PLs' effects on Abeta production.
authors.affiliation: Zentrum für Molekulare Biologie Heidelberg, University of Heidelberg, Germany. zamtul@uwo.ca
authors.forename: Zareen
authors.initials: Z
authors.lastname: Amtul
authors.forename: Markus
authors.initials: M
authors.lastname: Uhrig
authors.forename: Rosanna
authors.initials: R
authors.lastname: Supino
authors.forename: Konrad
authors.initials: K
authors.lastname: Beyreuther
mesh_terms: D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D019556:COS Cells; D002308:Cardiolipins / Q000494:pharmacology; D002522:Chlorocebus aethiops; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D010446:Peptide Fragments / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000494:pharmacology; D010743:Phospholipids / Q000494:pharmacology*; D013109:Sphingomyelins / Q000494:pharmacology*
chemical_list: D016229:Amyloid beta-Peptides; D002308:Cardiolipins; D010446:Peptide Fragments; D010716:Phosphatidylinositols; D010743:Phospholipids; D013109:Sphingomyelins; C078592:amyloid beta-protein (1-40); C075222:amyloid beta-protein (1-42)